BELITE BIO, INC insiders: buys and sells · BLTE

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-09-04 and 2026-10-01. All filings on SEC EDGAR →

Bought: $0
Sold: $31,968,735
Buys: 0
Sells: 46

The 46 transactions

Date	Who	Role	Transaction	Shares	Price	Amount
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	200	163,62	$32,725
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	120	165,49	$19,859
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	78	167,59	$13,072
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	50	166,44	$8,322
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	24	164,64	$3,951
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	14	169,36	$2,371
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	12	168,21	$2,019
2026-10-01	Scholl Hendrik Peter	Chief Medical Officer	sell	2	170,02	$340
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	sell	8.752	197,36	$1,727,275
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	sell	6.090	195,62	$1,191,325
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	sell	6.058	196,54	$1,190,642
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	sell	4.605	197,23	$908,244
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	sell	4.475	196,47	$879,200
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	sell	4.120	195,60	$805,889
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	sell	2.700	198,09	$534,845
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	sell	2.562	198,05	$507,392
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	sell	2.400	194,33	$466,399
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	sell	2.200	194,28	$427,414
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	11.080	191,15	$2,117,909
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	8.955	189,34	$1,695,552
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	8.111	193,13	$1,566,439
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	7.800	186,32	$1,453,323
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	6.200	191,09	$1,184,754
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	6.200	189,22	$1,173,191
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	6.200	187,25	$1,160,964
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	6.252	184,52	$1,153,647
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	4.955	183,30	$908,228
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	4.602	193,12	$888,727
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	4.600	186,34	$857,187
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	4.593	185,34	$851,286
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	4.209	192,54	$810,412
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	3.900	187,16	$729,942
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	3.872	185,28	$717,408
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	3.759	183,27	$688,899
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	3.569	184,57	$658,744
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	3.398	192,40	$653,788
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	3.413	182,50	$622,869
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	3.045	188,26	$573,253
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	2.635	180,29	$475,071
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	2.587	181,24	$468,877
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	2.000	182,49	$364,985
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	2.000	181,05	$362,107
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	1.900	188,59	$358,318
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	1.800	190,63	$343,140
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	sell	1.633	180,16	$294,201
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	sell	600	190,39	$114,232

How to read these transactions

There are 46 filed transactions for BELITE BIO, INC (BLTE) between 2026-09-04 and 2026-10-01. They were made by 3 different people. Open-market buys: 0, for $0. Sells: 46, for $31,968,735.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

Bumble Inc. (BMBL) · BlackRock 2037 Municipal Target Term Trust (BMN) · Bank of Marin Bancorp (BMRC) · BRISTOL MYERS SQUIBB CO (BMY) · Bionano Genomics, Inc. (BNGO) · BioNTech SE (BNTX) · Bank of New York Mellon Corp (BNY) · Boundless Bio, Inc. (BOLD)

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account